Best Life Sciences Companies in Portugal
The 102 best Life Sciences companies in Portugal in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Adapttech.
Portugal's Life Sciences sector doesn't have a unicorn yet, but $32M in disclosed funding across 102 tracked companies tells you there's real capital moving here. Adapttech leads the pack at $7M, followed by Biopremier at $6M and iLoF at $5M, with Portugal Ventures and the EIC Fund showing up repeatedly as the backers keeping this ecosystem alive. The global market these companies are feeding into was valued at roughly $167.8B with a 10.2% CAGR, driven by an aging population and accelerating institutional funding. And globally, the momentum is visible: Sai Life Sciences' IPO push and Asahi Songwon's API acquisition both signal that consolidation and public markets are heating up across the sector.
So what does that mean for Portugal specifically? The funding base is modest but concentrated, which I'd argue makes it easier to spot who's genuinely building. Stemmatters and CellmAbs each sit at $2M, while Glooma is still early. European Union and PME Investimentos rounding out the investor list suggests public co-funding structures are doing a lot of the heavy lifting. The sector isn't flush, but it's directionally right.
- Morgan Stanley Ups the Ante on These 2 Life Science Tool Stocks
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Portugal
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Adapttech Provider of smart prosthetic technology for orthopedic rehabilitation | $7M | 50 mo ago | Series A | — | 2015 | — | — | — |
| 2 | Biopremier Provider of molecular biology and DNA sequencing services in the food sector | $6M | 180 mo ago | Acquired | — | 2003 | Cart FunctionalitynopCommercePlesk+11 | — | 1 launch |
| 3 | iLoF Developer of therapeutics for Alzheimer's disease | $5M | 36 mo ago | Series A | Joana Paiva Founder & CTO | 2019 | WordPressMySQLPHP+16 | — | — |
| 4 | Stemmatters Regenerative medicine for osteoarticular, nerve tissue and hepatic conditions | $2M | 68 mo ago | Series A | — | 2007 | WordPressMySQLPHP+15 | — | — |
| 5 | Biomode Nucleic-acid based assays for food safety and infectious diseases | $2M | 135 mo ago | Series A | Nuno Azevedo Co-Founder | 2010 | — | — | — |
| 6 | CellmAbs Provider of therapeutic for oncology treatment | $2M | 64 mo ago | Seed | Paula Videira Co-Founder | 2018 | — | 2 patents Humanized therapeutic antibodies targeting cancer-associated antigens | — |
| 7 | Ophiomics Precision medicine solutions for chronic diseases | $1M | 60 mo ago | Seed | Jose Pereira-Leal Founder | 2015 | — | — | — |
| 8 | pCPR Developer of a cardiopulmonary resuscitation device | $1M | 119 mo ago | Seed | Nuno Freitas CEO | 2016 | — | — | — |
| 9 | Cell2B Develops stem cell therapeutics for immune disorders. | $1M | 180 mo ago | Deadpooled | — | 2011 | — | — | — |
| 10 | Criam Knowledge Provider of point-of-care diagnostic device for blood analysis | $1M | 54 mo ago | Seed | Vitor Crespo CEO | 2016 | — | — | — |
| 11 | Exogenus Therapeutics An exosome based therapeutics solutions for skin lesions | $962K | 110 mo ago | Seed | Joana Correia Founder | 2015 | WordPressMySQLPHP+12 | 10 patents Extracellular vesicle therapeutics derived from microalgae and umbilical cord cells for inflammation and fibrosis treatment. | — |
| 12 | Coimbra Genomics Provider of precision medicine solutions for healthcare providers | $600K | 155 mo ago | Deadpooled | Bruno Soares CEO | 2013 | — | — | — |
| 13 | Lymphact Developing gamma-delta T-cell based therapeutics to treat cancer. | $570K | 156 mo ago | Seed | Diogo Anjos CEO & Co-Founder | 2013 | — | — | — |
| 14 | Perceive3D Computer vision solutions for medical endoscopies. | $562K | 84 mo ago | Seed | Joao Barreto Co-Founder | 2013 | — | — | — |
| 15 | FASTinov Assay solutions to perform antimicrobial susceptibility testing (AST) for early microbial detection | $503K | 114 mo ago | Seed | Cidalia Pina Vaz Co-Founder & CEO | 2013 | WordPress Block EditorMaster SliderWordPress+25 | 12 patents Clinical microbiology diagnostics and therapeutic drug monitoring platforms for antimicrobial agents | — |
| 16 | Glooma Developer of a screening device for breast cancer | $364K | 29 mo ago | Seed | Francisco Nogueira Co-Founder & CEO | 2021 | Cart FunctionalityTailwind CSSAstro+9 | — | — |
| 17 | Zeyton Developer of mediterranean diet molecule products | $218K | 143 mo ago | Seed | Ana Nunes Co-Founder | — | — | — | — |
Top 12 Life Sciences companies in Portugal
#1
Series A · Porto, Porto District · founded 2019 · 31 employees$5.1Mraised▾
Developer of therapeutics for Alzheimer's disease. The company is developing Alzheimer’s drug discovery using bio-photonics and AI technology. The company uses AI to reduce the cost of clinical trials. It also offers PET and lumbar puncture for invasiveness and inconvenience of screening procedures.
#2
Series A · Porto, Porto District · founded 2015 · 28 employees$7.4Mraised▾
Provider of smart prosthetic technology for orthopedic rehabilitation. In most prosthetics, there is a lack of adaptation between the stump of the amputee and his/her prosthesis socket which causes discomfort. Adapttech uses novel, smart and wearable technologies to deliver full adaptation and greater comfort in a very short period of time.
#3
Seed · Braga, Braga District · founded 2021 · 10 employees$364.3Kraised▾
Developer of a screening device for breast cancer. It offers a SenseGlove portable medical screening device that detects an abnormality in the texture of the breast tissue. It analyzes the difference between the pressures of healthy breast tissue.
- Jan 2024Seed$364.3K
#4
Acquired · Lisbon, Lisbon · founded 2003 · 30 employees$5.9Mraised▾
Provider of molecular biology and DNA sequencing services in the food sector. The company has developed solutions based on Next Generation Sequencing (NGS). This enables species identification of meat, seafood, plants, allergens, and other microorganisms present in food products. It has an ISO 17025 accredited laboratory.
#5
Series A · Guimaraes, Braga District · founded 2007 · 28 employees$2.2Mraised▾
Stemmatters, a spin-off company from the University of Minho is focused on developing tissue-engineered products for the treatment of specific cartilage conditions such as post-traumatic and degenerative conditions.Its therapeutics unit has developed a proprietary technology platform based on stem cells and biomaterials. Its lead candidate is in preclinical trials for articular cartilage lesion treatment. It is also developing candidates for spinal cord injury repair and hepatic lesion degeneration. Additionally, it is developing a medical device for Osteoarthritis management. It also provides services for tissue processing, cell-based products manufacturing and stem cell banking.
#6
Seed · Lisbon, Lisbon · founded 2018 · 5 employees$1.6Mraised▾
Developer of therapeutic cancer drugs designed to deliver cancer immunotherapies that prevent tumor cells from evading the immune system by hitting sugar molecules only found on the surface. The company's cancer cells called aberrant glycans that are able to suppress immune cells that would normally kill tumor cells, enabling oncologists to bypass the disadvantages associated with the traditional inhibitors by using a new form of cancer drug that opens up immunotherapy to more patients.
#7
Seed · Braga, Braga District · founded 2016 · 9 employees$1Mraised▾
Provider of point-of-care diagnostic device for blood analysis. The company has developed portable in vitro diagnostic devices providing rapid analysis for blood-type, sub-type, diseases, and nutrients. It can be used to test blood type before a blood transfusion.
#8
Seed · Lisbon, Lisbon · founded 2015 · 13 employees$1.2Mraised▾
Ophiomics is a molecular diagnostics company enabling clinicians to deliver preventive and personalized medicine. It develops and commercializes genetic and genomic tests focused on specific clinical decisions. With a focus on chronic diseases (including cancer), it offers tests based on DNA sequencing, where the starting sample is blood in the context of susceptibility, early detection and follows up studies, and tumor biopsies (fresh/FFPE) for pharmacogenomic tests. Besides, it also works at developing better services in support of a precision medicine. As of Jul 2017, the company is incubating at Healthcare City.
#9
Series A · Guimaraes, Braga District · founded 2010 · 2 employees$1.7Mraised▾
Developer of genetic diagnostic kits designed to identify and detect foodborne and clinical pathogens. The company's genetic diagnostic kits specialized in Peptide Nucleic Acid FISH (PNA-FISH) technology which do not involve DNA extraction or amplification, is not susceptible to inhibitory compounds, and only detects viable bacterial cells, enabling the health and food safety industry to have a fast, reliable, easy and cost-efficient pathogen detection assay for their laboratory daily demands in food and clinical analysis.
#10
Funding Raised · Faro, Faro District · founded 2022$81.9Kraised▾
Provider of RNA analysis test kits for personalized medicine and treatment decisions. The company harnesses the power of RNA analysis to provide a comprehensive understanding of a patient's tumour genetic profile, enabling healthcare providers make informed decisions about tailored treatment options.
- Jul 2023Grant (prize money)$81.9K
#11
Seed · Coimbra, Coimbra District · founded 2016$1.1Mraised▾
Developer of a cardio-assistive medical device designed to analyze cardiac data and optimize heart surgeries in cardiopulmonary resuscitation. The company's device combines thoracic pad with non-invasive sensors linked to a helpful defib monitor display that offers clinical feedback, personalized guidance and therapy and emergency data management on heart's conditions and beat rates in real time, enabling cardiac surgeons to sense, monitor and utilize cardiac data to perform safer and quicker heart surgeries cost effectively.
#12
Seed · Cantanhede, Coimbra District · founded 2015 · 10 employees$961.8Kraised▾
Developer of an exosome-based platform technology designed to offer an innovative pipeline of therapeutic products. The company's platform leverages the strong regenerative, anti-inflammatory and immunomodulatory properties of proprietary vesicles, enabling healthcare providers to access a pipeline of products for skin and autoimmune diseases.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.